Appistry Announces Solutions to Automate NGS Data Analysis

Appistry announces integrated solutions that automate NGS workflows to help clinical labs reduce the barrier of entry and costs associated with NGS based testing. 

Expanding on Appistry’s current NGS analysis offering, the end-to-end solution features new interpretation capabilities within GenomeNavigator™ and leverages the genomics workflow platform from GenomePilot™ to automate the entire process from reads to report.  

“One of the biggest challenges for a lab running NGS based tests or one looking to start, is the barrier of entry and costs associated with analyzing  the sequencing data,” said Kevin Haar CEO of Appistry. “We have found lab directors require more than the disparate bioinformatics platforms and interpretation tools available on the market today. Instead of addressing pieces of the workflow, our goal is to enable the automation of the entire workflow, providing an easier path for labs to establish or expand their NGS testing capabilities and improve productivity and costs.”

Appistry’s GenomePilot will automate the execution of NGS tests from the lab’s sequencer through the identification, qualification and prioritization of variants. Each case is presented in GenomeNavigator for first review, where a molecular pathologist can either approve the prioritized variants for clinical reporting, or in more complex cases, conduct further investigation using GenomeNavigator’s interactive interpretation environment.

Appistry will debut their end-to-end solution during the week of September 19th at two industry conferences.

• Festival of Genomics California:  Appistry will co-sponsor the Live Data Lab with partner Dell EMC where visitors can test-drive Appistry’s solutions and learn more about automating their NGS workflows.   

• AGBT Precision Health Meeting – Visitors can visit Appistry booth #10 and receive 1:1 demonstrations.